Quality management e-education/e-training sessions on pre-analytical standards for tissue & blood

Starting October 2020, BBMRI.QM launches a series of webinars the pre-analytical ISO standards “In vitro diagnostic examinations — Specifications for pre-examination processes” for tissue & blood intended for the analysis of isolated RNA, DNA, proteins etc. This is done in cooperation with the H2020 project SPIDIA4P GA 733112.

Speakers:

Among the speakers are experts from the ISO technical committee who contributed to the development of the standards. E.g. Uwe Oelmueller, Peter Riegman, Kurt Zatloukal, Cornelia Stumptner, Andrea Wutte, Karl-Friedrich Becker, Daniel Groelz, Stefania Gelmini, Kalle Guenther, Pamela Pinzani

Standards discussed in detail in the webinars:

  • ISO 20166-1: Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for formalin-fixed and paraffin-embedded (FFPE) tissue — Part 1: Isolated RNA
  • ISO 20166-2: Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for formalin-fixed and paraffin-embedded (FFPE) tissue — Part 3: Isolated Proteins
  • ISO 20166-3: Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for formalin-fixed and paraffin-embedded (FFPE) tissue — Part 3: Isolated DNA
  • ISO 20184-1: Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for frozen tissue — Part 1: Isolated RNA
  • ISO 20184-2. Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for frozen tissue — Part 2: Isolated proteins
  • ISO 20186-1: Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for venous whole blood — Part 1: Isolated cellular RNA
  • ISO 20186-2:2019. Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for venous whole blood — Part 2: Isolated genomic DNA
  • ISO 20186-3:2019. Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for venous whole blood — Part 3: Isolated circulating cell free DNA from plasma